Methylprednisolone sodium succinate is an injectable corticosteroid used for its potent anti-inflammatory and immunosuppressive effects in treating a wide range of conditions when oral therapy is not an option. It is grouped under the following drug class(es): Steroids. Its therapeutic use is listed as antirheumatic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include 6a-Methylprednisolone 21-Hemisuccinate and Urbasonsoluble. Its PubChem CID is 16923.
Methylprednisolone succinate
| CAS No | 2921-57-5 |
|---|---|
| Molecular Formula | C26H34O8 |
| Molecular Weight | 474.50 g/mol |
| Synonyms | 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Methylprednisolone sodium succinate is an injectable corticosteroid used for its potent anti-inflammatory and immunosuppressive effects in treating a wide range of conditions when oral therapy is not an option.
The listed CAS number is 2921-57-5.
The listed molecular formula is C26H34O8.
The listed molecular weight is 474.50 g/mol.
4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid.
The source lists 6a-Methylprednisolone 21-Hemisuccinate and Urbasonsoluble.